These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34218085)

  • 21. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.
    Kapanda CN; Masquelier J; Labar G; Muccioli GG; Poupaert JH; Lambert DM
    J Med Chem; 2012 Jun; 55(12):5774-83. PubMed ID: 22651858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe.
    Miceli M; Casati S; Ottria R; Di Leo S; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).
    Granchi C; Caligiuri I; Minutolo F; Rizzolio F; Tuccinardi T
    Expert Opin Ther Pat; 2017 Dec; 27(12):1341-1351. PubMed ID: 29053063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S; Ayyannan SR
    ChemMedChem; 2021 Jul; 16(14):2172-2187. PubMed ID: 33834617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzisothiazolinone as a useful template for the design of new monoacylglycerol lipase inhibitors: investigation of the target residues and comparison with octhilinone.
    Matuszak N; Es Saadi B; Labar G; Marchand-Brynaert J; Lambert DM
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7321-4. PubMed ID: 22056744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analgesic and Anticancer Activity of Benzoxazole Clubbed 2-Pyrrolidinones as Novel Inhibitors of Monoacylglycerol Lipase.
    Afzal O; Altamimi ASA; Shahroz MM; Sharma HK; Riadi Y; Hassan MQ
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33924091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine Skeleton.
    Chen Z; Mori W; Deng X; Cheng R; Ogasawara D; Zhang G; Schafroth MA; Dahl K; Fu H; Hatori A; Shao T; Zhang Y; Yamasaki T; Zhang X; Rong J; Yu Q; Hu K; Fujinaga M; Xie L; Kumata K; Gou Y; Chen J; Gu S; Bao L; Wang L; Collier TL; Vasdev N; Shao Y; Ma JA; Cravatt BF; Fowler C; Josephson L; Zhang MR; Liang SH
    J Med Chem; 2019 Apr; 62(7):3336-3353. PubMed ID: 30829483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases.
    Zanfirescu A; Ungurianu A; Mihai DP; Radulescu D; Nitulescu GM
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors.
    Jiang M; Huizenga MCW; Mohr F; Amedi A; Bakker R; van den Berg RJBHN; Deng H; van der Wel T; van Boeckel CAA; van der Stelt M
    J Med Chem; 2024 Jul; 67(14):12331-12348. PubMed ID: 38988250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoacylglycerol lipase (MAGL) as a promising therapeutic target.
    Gil-Ordóñez A; Martín-Fontecha M; Ortega-Gutiérrez S; López-Rodríguez ML
    Biochem Pharmacol; 2018 Nov; 157():18-32. PubMed ID: 30059673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase.
    Aaltonen N; Savinainen JR; Ribas CR; Rönkkö J; Kuusisto A; Korhonen J; Navia-Paldanius D; Häyrinen J; Takabe P; Käsnänen H; Pantsar T; Laitinen T; Lehtonen M; Pasonen-Seppänen S; Poso A; Nevalainen T; Laitinen JT
    Chem Biol; 2013 Mar; 20(3):379-90. PubMed ID: 23521796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors.
    Szabo M; Agostino M; Malone DT; Yuriev E; Capuano B
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6782-7. PubMed ID: 21982493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present).
    Bononi G; Poli G; Rizzolio F; Tuccinardi T; Macchia M; Minutolo F; Granchi C
    Expert Opin Ther Pat; 2021 Feb; 31(2):153-168. PubMed ID: 33085920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S; Ayyannan SR
    ChemMedChem; 2022 Jan; 17(1):e202100559. PubMed ID: 34637598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The medicinal chemistry of agents targeting monoacylglycerol lipase.
    Viso A; Cisneros JA; Ortega-Gutiérrez S
    Curr Top Med Chem; 2008; 8(3):231-46. PubMed ID: 18289090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors.
    Di Stefano M; Masoni S; Bononi G; Poli G; Galati S; Gado F; Manzi S; Vagaggini C; Brai A; Caligiuri I; Asif K; Rizzolio F; Macchia M; Chicca A; Sodi A; Di Bussolo V; Minutolo F; Meier P; Gertsch J; Granchi C; Dreassi E; Tuccinardi T
    Eur J Med Chem; 2024 Jan; 263():115916. PubMed ID: 37976705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.